(Q35106506)

6 August 2017

1 reference

title

Pharmacogenomics of congestive heart failure (English)

1 reference

6 August 2017

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12693740

23 December 2023

congestive heart failure

1 reference

Jagat Narula

1 reference

6 August 2017

Ragavendra R. Baliga

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12693740

23 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12693740

23 December 2023

publication date

1 March 2003

1 reference

full work available at URL

6 August 2017

https://api.elsevier.com/content/article/PII:S0025712502001785?httpAccept=text/xml

1 reference

10.1016/S0025-7125(02)00178-5

DOI

https://api.crossref.org/works/10.1016/S0025-7125(02)00178-5

https://api.elsevier.com/content/article/PII:S0025712502001785?httpAccept=text/plain

23 December 2023

1 reference

10.1016/S0025-7125(02)00178-5

DOI

https://api.crossref.org/works/10.1016/S0025-7125(02)00178-5

Medical Clinics of North America

23 December 2023

published in

1 reference

6 August 2017

1 reference

6 August 2017

1 reference

6 August 2017

page(s)

569-78, xiv

1 reference

Effect of carvedilol on survival in severe chronic heart failure

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900178-5

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900178-5

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900178-5

A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900178-5

Implications of the Human Genome Project for medical science.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900178-5

Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900178-5

Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900178-5

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900178-5

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900178-5

Angiotensin-converting enzyme genotype modulates pulmonary function and exercise capacity in treated patients with congestive stable heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900178-5

Deletion-type allele of the angiotensin-converting enzyme gene is associated with progressive ventricular dilation after anterior myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900178-5

Effect of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene on response to angiotensin-converting enzyme inhibitors in patients with heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900178-5

Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900178-5

Pharmacogenetic interactions between beta-blocker therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900178-5

Arg389Gly beta 1-adrenoceptor polymorphism varies in frequency among different ethnic groups but does not alter response in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900178-5

The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900178-5

The Ile164 beta2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900178-5

Polymorphisms of the beta(2)-adrenergic receptor determine exercise capacity in patients with heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900178-5

Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900178-5

Adrenergic-receptor polymorphisms and heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900178-5

Stereoselective disposition of carvedilol is determined by CYP2D6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900178-5

Racial differences in the response to drugs--pointers to genetic differences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900178-5

Bradykinin B(2) receptor gene polymorphism is associated with angiotensin-converting enzyme inhibitor-related cough

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900178-5

An aldosterone synthase gene variant is associated with improvement in left ventricular ejection fraction in dilated cardiomyopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900178-5

Naturally occurring variation in cardiovascular traits among inbred mouse strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900178-5

Challenges of comparative expression profiling studies of complex diseases: mouse models of myocardial hypertrophy. Focus on "Divergent transcriptional responses to independent genetic causes of cardiac hypertrophy"

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900178-5

A genome-based resource for molecular cardiovascular medicine: toward a compendium of cardiovascular genes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900178-5

Angiotensin I-converting enzyme gene polymorphism and salt sensitivity in essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900178-5

Molecular basis of salt sensitivity in human hypertension. Evaluation of renin-angiotensin-aldosterone system gene polymorphisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900178-5

10.1016/S0025-7125(02)00178-5

7 January 2021

Identifiers

DOI

1 reference

6 August 2017

1 reference